Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Integer Holdings Corp (ITGR)

  • Business News
  • Jan. 09, 2026, 21:12 UTC
  • 9
  • 1 comments

Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

Praxis Precisions Medicines Inc (PRAX)

  • Business News
  • Jan. 09, 2026, 21:01 UTC
  • 8
  • 1 comments

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

CorMedix Inc. (CRMD)

  • Business News
  • Jan. 09, 2026, 20:13 UTC
  • 8
  • 1 comments

Notification from CorMedix Inc.

Market reaction Comment Full text

Smart for Life, Inc. (SMFL)

  • Business News
  • Jan. 09, 2026, 20:13 UTC
  • 10
  • 1 comments

WE26 Call for Participation for Breakout Sessions Now Open!

Market reaction Comment Full text

China SXT Pharmaceuticals Inc. (SXTC)

  • Business News
  • Jan. 09, 2026, 19:50 UTC
  • 8
  • 1 comments

China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering

Market reaction Comment Full text

Assertio Holdings Inc. (ASRT)

  • Business News
  • Jan. 09, 2026, 18:45 UTC
  • 7
  • 1 comments

Assertio Holdings, Inc. - Assertio Announces Publication ofRolvedon® Same-Day Dosing Clinical Trial

Market reaction Comment Full text

Assertio Holdings Inc. (ASRT)

  • Business News
  • Jan. 09, 2026, 18:45 UTC
  • 8
  • 1 comments

Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

Market reaction Comment Full text

IDEXX Laboratories Inc. (IDXX)

  • Business News
  • Jan. 09, 2026, 18:30 UTC
  • 9
  • 1 comments

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

Market reaction Comment Full text

Vera Therapeutics Inc. (VERA)

  • Business News
  • Jan. 09, 2026, 18:05 UTC
  • 7
  • 1 comments

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Qiagen N.V. (QGEN)

  • Business News
  • Jan. 09, 2026, 17:30 UTC
  • 7
  • 1 comments

QIAGEN announces adjustment of conversion price under its US$750,000,000 Convertible Bonds due 2032

Market reaction Comment Full text
  • Previous
  • 108
  • 109
  • 110
  • 111
  • 112
  • Next

Search

News categories

  • Technical Exchange News(10868)
  • Event(2242)
  • SEC News(189083)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124501)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin